- Home
- WHD vs AXSM Comparison
WHD vs AXSM Comparison
Compare WHD & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WHD
- AXSM
- Stock Information
- Founded
- WHD 2011
- AXSM 2012
- Country
- WHD United States
- AXSM United States
- Employees
- WHD N/A
- AXSM N/A
- Industry
- WHD Metal Fabrications
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- WHD Industrials
- AXSM Health Care
- Exchange
- WHD Nasdaq
- AXSM Nasdaq
- Market Cap
- WHD 3.8B
- AXSM 4.2B
- IPO Year
- WHD 2018
- AXSM 2015
- Fundamental
- Price
- WHD $60.38
- AXSM $84.60
- Analyst Decision
- WHD Hold
- AXSM Strong Buy
- Analyst Count
- WHD 6
- AXSM 14
- Target Price
- WHD $56.40
- AXSM $125.54
- AVG Volume (30 Days)
- WHD 575.8K
- AXSM 893.5K
- Earning Date
- WHD 02-26-2025
- AXSM 02-18-2025
- Dividend Yield
- WHD 0.86%
- AXSM N/A
- EPS Growth
- WHD 21.87
- AXSM N/A
- EPS
- WHD 2.84
- AXSM N/A
- Revenue
- WHD $1,132,559,000.00
- AXSM $338,457,000.00
- Revenue This Year
- WHD $4.29
- AXSM $44.77
- Revenue Next Year
- WHD $3.23
- AXSM $67.70
- P/E Ratio
- WHD $21.29
- AXSM N/A
- Revenue Growth
- WHD 12.15
- AXSM 51.47
- 52 Week Low
- WHD $37.58
- AXSM $64.11
- 52 Week High
- WHD $70.01
- AXSM $105.00
- Technical
- Relative Strength Index (RSI)
- WHD 48.57
- AXSM 43.66
- Support Level
- WHD $58.57
- AXSM $79.19
- Resistance Level
- WHD $61.85
- AXSM $87.53
- Average True Range (ATR)
- WHD 1.57
- AXSM 4.37
- MACD
- WHD 0.43
- AXSM -0.02
- Stochastic Oscillator
- WHD 75.04
- AXSM 61.27
About WHD Cactus Inc.
Cactus Inc is engaged in the designing, manufacturing, and sale of wellheads and pressure control equipment. Its principal products include Cactus SafeDrill wellhead systems, conventional wellheads, and production valves among others. The company also provides mission-critical field services, including service crews to assist with the installation, maintenance, and safe handling of the wellhead and pressure control equipment, as well as repair services for equipment that it sells or rents. It sells or rents its products principally for onshore unconventional oil and gas wells that are utilized during the drilling, completion (including fracturing), and production. The company has two operating segments; Pressure Control , which generates key revenue and Spoolable Technologies.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.